ARTICLE | Company News
Gliacor Therapeutics, PsychoGenics, The Michael J. Fox Foundation for Parkinson's Research neurology news
August 13, 2012 7:00 AM UTC
The foundation named PsychoGenics and Gliacor as the 3Q12 participants in its Partnering Program. The program presents participants' projects to potential investors. PsychoGenics' eltoprazine, a selec...